0001486430-14-000004.txt : 20140501
0001486430-14-000004.hdr.sgml : 20140501
20140501180436
ACCESSION NUMBER: 0001486430-14-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140430
FILED AS OF DATE: 20140501
DATE AS OF CHANGE: 20140501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERNIX THERAPEUTICS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001024126
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330724736
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 884 JOHNNIE DODDS BLVD
STREET 2: SUITE 201
CITY: MOUNT PLEASANT
STATE: SC
ZIP: 29464
BUSINESS PHONE: (832) 934-1825
MAIL ADDRESS:
STREET 1: 884 JOHNNIE DODDS BLVD
STREET 2: SUITE 201
CITY: MOUNT PLEASANT
STATE: SC
ZIP: 29464
FORMER COMPANY:
FORMER CONFORMED NAME: GOLF TRUST OF AMERICA INC
DATE OF NAME CHANGE: 19961002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith James Edward Jr.
CENTRAL INDEX KEY: 0001486430
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14494
FILM NUMBER: 14806319
MAIL ADDRESS:
STREET 1: 33219 FOREST WEST DRIVE
CITY: MAGNOLIA
STATE: TX
ZIP: 77354
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-04-30
0
0001024126
PERNIX THERAPEUTICS HOLDINGS, INC.
PTX
0001486430
Smith James Edward Jr.
700 CAMP STREET
NEW ORLEANS
LA
70130
0
0
1
0
Common Stock
2014-04-30
4
S
0
15000
4.7193
D
4397704
D
Common Stock
2014-05-01
4
S
0
15000
4.6324
D
4382704
D
Common Stock
3200
I
By Daughter
The sales reported in the Form 4 were effected pursuant to Rule 144.
The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.59 to $4.81, inclusive. The reporting person will provide Pernix Therapeutics Holdings, Inc, any security holder of Pernix Therapeutics Holdings, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.53 to $4.79, inclusive. The reporting person will provide Pernix Therapeutics Holdings, Inc, any security holder of Pernix Therapeutics Holdings, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Smith James Edward Jr
2014-05-01